NO963850D0 - Heterosykliske forbindelser, deres fremstilling og anvendelse - Google Patents
Heterosykliske forbindelser, deres fremstilling og anvendelseInfo
- Publication number
- NO963850D0 NO963850D0 NO963850A NO963850A NO963850D0 NO 963850 D0 NO963850 D0 NO 963850D0 NO 963850 A NO963850 A NO 963850A NO 963850 A NO963850 A NO 963850A NO 963850 D0 NO963850 D0 NO 963850D0
- Authority
- NO
- Norway
- Prior art keywords
- heterocyclic compounds
- preparation
- compounds
- preparing
- useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK29594 | 1994-03-14 | ||
| PCT/DK1995/000115 WO1995025110A1 (en) | 1994-03-14 | 1995-03-10 | Heterocyclic compounds, their preparation and use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO963850D0 true NO963850D0 (no) | 1996-09-13 |
| NO963850L NO963850L (no) | 1996-11-14 |
Family
ID=8091942
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO963850A NO963850L (no) | 1994-03-14 | 1996-09-13 | Heterosykliske forbindelser, deres fremstilling og anvendelse |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5536721A (no) |
| EP (1) | EP0750621B1 (no) |
| JP (1) | JPH09510223A (no) |
| KR (1) | KR970701719A (no) |
| CN (1) | CN1144529A (no) |
| AT (1) | ATE182333T1 (no) |
| AU (1) | AU697183B2 (no) |
| BR (1) | BR9507073A (no) |
| CA (1) | CA2185670A1 (no) |
| CZ (1) | CZ265096A3 (no) |
| DE (1) | DE69510928D1 (no) |
| HU (1) | HUT76543A (no) |
| IL (1) | IL112957A0 (no) |
| MX (1) | MX9604023A (no) |
| NO (1) | NO963850L (no) |
| PL (1) | PL316239A1 (no) |
| WO (1) | WO1995025110A1 (no) |
| ZA (1) | ZA952086B (no) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11509846A (ja) * | 1995-07-31 | 1999-08-31 | ノボ ノルディスク アクティーゼルスカブ | ヘテロ環式化合物、それらの調製及び使用 |
| US6017903A (en) | 1996-09-27 | 2000-01-25 | Guilford Pharmaceuticals Inc. | Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors |
| US5824662A (en) * | 1996-09-27 | 1998-10-20 | Guilford Pharmaceuticals Inc. | Treatment of global and focal ischemia using naaladase inhibitors |
| AU3783497A (en) * | 1996-08-09 | 1998-03-06 | Yamanouchi Pharmaceutical Co., Ltd. | Metabotropic glutamate receptor agonists |
| PL332413A1 (en) | 1996-09-27 | 1999-09-13 | Guilford Pharm Inc | Compositions containing inhibitors of naaladase as well as methods of treating glutamatic anomaly and influencing neuronic functions among animals |
| DE19801647A1 (de) | 1998-01-17 | 1999-07-22 | Bayer Ag | Substituierte beta,gamma-annellierte Lactone |
| DE19801636A1 (de) | 1998-01-17 | 1999-07-22 | Bayer Ag | Substituierte bicyclische Lactone |
| DE19801646A1 (de) | 1998-01-17 | 1999-07-22 | Bayer Ag | Substituierte alpha,beta-annellierte Butyrolactone |
| AU2241400A (en) | 1999-04-06 | 2000-10-12 | Yamanouchi Pharmaceutical Co., Ltd. | Novel thiazolobenzoimidazole derivative |
| US7582635B2 (en) * | 2002-12-24 | 2009-09-01 | Purdue Pharma, L.P. | Therapeutic agents useful for treating pain |
| US7678363B2 (en) | 2005-08-26 | 2010-03-16 | Braincells Inc | Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs |
| EP2258358A3 (en) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
| EP1940389A2 (en) | 2005-10-21 | 2008-07-09 | Braincells, Inc. | Modulation of neurogenesis by pde inhibition |
| US20070112017A1 (en) | 2005-10-31 | 2007-05-17 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| AU2007249399A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| MX2008014320A (es) | 2006-05-09 | 2009-03-25 | Braincells Inc | Neurogenesis mediada por el receptor de 5-hidroxitriptamina. |
| JP2010502722A (ja) | 2006-09-08 | 2010-01-28 | ブレインセルス，インコーポレイティド | ４−アシルアミノピリジン誘導体を含む組み合わせ |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| HUE032743T2 (en) | 2006-11-22 | 2017-10-30 | Clinical Res Ass Llc | A method for treating Down syndrome, fragilis X syndrome and autism |
| WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| WO2011109398A2 (en) | 2010-03-02 | 2011-09-09 | President And Fellows Of Harvard College | Methods and compositions for treatment of angelman syndrome and autism spectrum disorders |
| US20110294879A1 (en) | 2010-05-28 | 2011-12-01 | Xenoport, Inc. | Method of treatment of fragile x syndrome, down's syndrome, autism and related disorders |
| US20120016021A1 (en) | 2010-07-15 | 2012-01-19 | Xenoport, Inc. | Methods of treating fragile x syndrome, down's syndrome, autism and related disorders |
| RU2451686C1 (ru) * | 2010-12-27 | 2012-05-27 | Александр Васильевич Иващенко | ЗАМЕЩЕННЫЕ ГИДРИРОВАННЫЕ ТИЕНО-ПИРРОЛО [3,2-c] ПИРИДИНЫ, ЛИГАНДЫ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И СПОСОБ ИХ ПРИМЕНЕНИЯ |
| CN108218897B (zh) * | 2018-03-02 | 2020-12-11 | 湘潭大学 | 多取代硒吩并吲哚及衍生物及其合成方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4464384A (en) * | 1981-12-23 | 1984-08-07 | Yamanouchi Pharmaceutical Co., Ltd. | 2-Phenylimidazo[2,1-b]benzothiazole compounds, salts thereof, process of producing them, and pharmaceutical compositions containing them |
-
1995
- 1995-03-10 PL PL95316239A patent/PL316239A1/xx unknown
- 1995-03-10 EP EP95912146A patent/EP0750621B1/en not_active Expired - Lifetime
- 1995-03-10 AT AT95912146T patent/ATE182333T1/de not_active IP Right Cessation
- 1995-03-10 HU HU9602522A patent/HUT76543A/hu unknown
- 1995-03-10 AU AU19457/95A patent/AU697183B2/en not_active Ceased
- 1995-03-10 CN CN95192120A patent/CN1144529A/zh active Pending
- 1995-03-10 KR KR1019960705092A patent/KR970701719A/ko not_active Application Discontinuation
- 1995-03-10 MX MX9604023A patent/MX9604023A/es unknown
- 1995-03-10 JP JP7523786A patent/JPH09510223A/ja active Pending
- 1995-03-10 IL IL11295795A patent/IL112957A0/xx unknown
- 1995-03-10 CZ CZ962650A patent/CZ265096A3/cs unknown
- 1995-03-10 DE DE69510928T patent/DE69510928D1/de not_active Expired - Lifetime
- 1995-03-10 WO PCT/DK1995/000115 patent/WO1995025110A1/en not_active Application Discontinuation
- 1995-03-10 BR BR9507073A patent/BR9507073A/pt not_active Application Discontinuation
- 1995-03-10 CA CA002185670A patent/CA2185670A1/en not_active Abandoned
- 1995-03-14 US US08/403,357 patent/US5536721A/en not_active Expired - Fee Related
- 1995-03-14 ZA ZA952086A patent/ZA952086B/xx unknown
-
1996
- 1996-09-13 NO NO963850A patent/NO963850L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA952086B (en) | 1996-09-16 |
| EP0750621A1 (en) | 1997-01-02 |
| ATE182333T1 (de) | 1999-08-15 |
| HUT76543A (en) | 1997-09-29 |
| US5536721A (en) | 1996-07-16 |
| CN1144529A (zh) | 1997-03-05 |
| MX9604023A (es) | 1997-09-30 |
| HU9602522D0 (en) | 1996-11-28 |
| BR9507073A (pt) | 1997-09-09 |
| CA2185670A1 (en) | 1995-09-21 |
| PL316239A1 (en) | 1997-01-06 |
| AU1945795A (en) | 1995-10-03 |
| IL112957A0 (en) | 1995-06-29 |
| EP0750621B1 (en) | 1999-07-21 |
| NO963850L (no) | 1996-11-14 |
| AU697183B2 (en) | 1998-10-01 |
| KR970701719A (ko) | 1997-04-12 |
| DE69510928D1 (de) | 1999-08-26 |
| WO1995025110A1 (en) | 1995-09-21 |
| JPH09510223A (ja) | 1997-10-14 |
| CZ265096A3 (en) | 1997-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO963850L (no) | Heterosykliske forbindelser, deres fremstilling og anvendelse | |
| UA44254C2 (uk) | Похідні 4-(заміщеного феніламіно)хіназоліну, спосіб їх одержання, спосіб лікування і фармацевтична композиція | |
| MXPA02001340A (es) | Compuestos novedosos 1,4-benzodiazepina y derivados de los mismos. | |
| ATE265419T1 (de) | Spiro(2.4)heptanaminocarbonsäure und ihre derivate | |
| SE9503924D0 (sv) | Novel opioid peptides | |
| BR9910130A (pt) | Derivados de cubana como antagonistas de receptor de glutamato metabotrópico e processo para a sua preparação | |
| ATE199013T1 (de) | N-(4-substituerte benzyl)-2-aminolactamderivate | |
| DK1039900T3 (da) | Farmaceutisk præparat indeholdende sibutramin og orlistat | |
| MX9403088A (es) | Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso. | |
| UA26403A (uk) | Похідhі n-заміщеhого 4-феhіл-4-піперидиhкарбоксаміду та їх фармацевтичhо прийhятhі солі, що проявляють аhестезувальhу та аhальгезувальhу дію, спосіб їх одержаhhя та фармацевтичhа композиція | |
| FI103116B1 (fi) | Menetelmä uusien, terapeuttisesti käyttökelpoisten, N-substituoitujen atsaheterosyklisten karboksyylihappojohdannaisten valmistamiseksi | |
| FR2767527B1 (fr) | Derives de piperazines indoliques, utiles comme medicaments et procede de preparation | |
| MXPA02000242A (es) | Analogos de 2-aminoindano. | |
| NO983860L (no) | Nye triazolopuriner, fremgangsmÕte for deres fremstilling og deres anvendelse som legemidler | |
| ZA979647B (en) | Heterocyclic compounds, compositions and uses. | |
| NO970573L (no) | Ylidenforbindelser og deres fremstilling | |
| WO2001002340A3 (en) | Novel aminoindanes | |
| DK0505400T3 (da) | N-substituerede naphthalimider, deres fremstilling og anvendelse | |
| DK1025101T3 (da) | Naphtho-imidazo[1,2-a]pyridinderivater, deres fremstilling og deres anvendelse ved behandlingen af sygdomme i centralnervesystemet | |
| AU2287197A (en) | Heterocyclic compounds and their preparation and use | |
| NO20001846L (no) | Nye farmasøytisk aktive forbindelser, deres fremstilling og anvendelse som ECE-inhibitorer | |
| DK0793665T3 (da) | Heterocykliske forbindelser og deres fremstilling og anvendelse | |
| NO993546D0 (no) | 1,4-dihydropyridinderivater og deres anvendelse i terapi | |
| TR200000916T2 (tr) | İkameli piperidin türevleri. | |
| SE9502877D0 (sv) | Novel opioid peptides |